Amylyx Pharmaceuticals Announces Launch Of Public Offering Of 6M Shares Of Common Stock
Amylyx Pharmaceuticals, Inc. ("Amylyx") today announced the launch of an underwritten public offering of 6,000,000 shares of common stock pursuant to a registration statement on Form S-1 filed with the U.S.